A randomized multi-center phase II trial of the angiogenesis inhibitor Cilengitide (EMD 121974) and gemcitabine compared with gemcitabine alone in advanced unresectable pancreatic cancer

被引:0
作者
Helmut Friess
Jan M Langrehr
Helmut Oettle
Jochen Raedle
Marco Niedergethmann
Christian Dittrich
Dieter K Hossfeld
Herbert Stöger
Bart Neyns
Peter Herzog
Pascal Piedbois
Frank Dobrowolski
Werner Scheithauer
Robert Hawkins
Frieder Katz
Peter Balcke
Jan Vermorken
Simon van Belle
Neville Davidson
Albert Abad Esteve
Daniel Castellano
Jörg Kleeff
Adrien A Tempia-Caliera
Andreas Kovar
Johannes Nippgen
机构
[1] University of Heidelberg,Department of General Surgery
[2] Charité,Department of General and Transplantation Surgery
[3] Virchow-Clinic,Department of Hematology and Oncology
[4] Charité,Department of Medicine II
[5] Virchow-Clinic,Department of Surgery
[6] University of Frankfurt Hospital,Ludwig Blotzmann
[7] University Hospital Mannheim,Institute for Applied Cancer Research (LBI
[8] Kaiser Franz Josef-Spital,ACR Vienna)
[9] University Hospital Hamburg-Eppendorf,Department of Oncology/Hematology
[10] Medical University of Graz,Department of Internal Medicine, Division of Oncology
[11] Oncology Center,Department of Medical Oncology
[12] Vrije Universiteit Brussel,Department of Gastroenterology
[13] Reinhardt Nieter Krankenhaus,Department of Medical Oncology
[14] Henri Mondor Hospital,Department of Visceral, Thoracic and Vascular Surgery
[15] University Hospital Carl Gustav Carus,Department of Internal Medicine I, Division of Clinical Oncology
[16] Technical University of Dresden,Department of Medical Oncology
[17] University Hospital of Vienna,Department of Medicine V
[18] Paterson Institute for Cancer Research,Department of Medicine
[19] University of Manchester,Department of Oncology
[20] Clinic Darmstadt,Department of Oncology
[21] Clinic of the City of St. Poelten,Department of Medicine
[22] University Hospital Antwerpen,Department of Oncology
[23] University Hospital Gent,Department of Oncology
[24] St John's Hospital,Department of Pharmacology and Pharmacokinetics
[25] Hospital Germans Trias i Pujol,Medical Center of Excellence Oncology
[26] Hospital Universitario 12 de Octubre,undefined
[27] Merck KGaA,undefined
[28] Merck KGaA,undefined
来源
BMC Cancer | / 6卷
关键词
Pancreatic Cancer; Gemcitabine; Serum Vascular Endothelial Growth Factor; National Cancer Institute Common Toxicity Criterion; Gemcitabine Group;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 228 条
  • [91] Sankila R(undefined)undefined undefined undefined undefined-undefined
  • [92] Ferlay J(undefined)undefined undefined undefined undefined-undefined
  • [93] Parkin DM(undefined)undefined undefined undefined undefined-undefined
  • [94] Haller DG(undefined)undefined undefined undefined undefined-undefined
  • [95] Burris HA(undefined)undefined undefined undefined undefined-undefined
  • [96] Moore MJ(undefined)undefined undefined undefined undefined-undefined
  • [97] Andersen J(undefined)undefined undefined undefined undefined-undefined
  • [98] Green MR(undefined)undefined undefined undefined undefined-undefined
  • [99] Rothenberg ML(undefined)undefined undefined undefined undefined-undefined
  • [100] Modiano MR(undefined)undefined undefined undefined undefined-undefined